DE69830596D1 - Ein tumorsuppressor namens ts10q23.3 - Google Patents

Ein tumorsuppressor namens ts10q23.3

Info

Publication number
DE69830596D1
DE69830596D1 DE69830596T DE69830596T DE69830596D1 DE 69830596 D1 DE69830596 D1 DE 69830596D1 DE 69830596 T DE69830596 T DE 69830596T DE 69830596 T DE69830596 T DE 69830596T DE 69830596 D1 DE69830596 D1 DE 69830596D1
Authority
DE
Germany
Prior art keywords
gene
region
tumor suppressor
demonstrated
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69830596T
Other languages
English (en)
Other versions
DE69830596T2 (de
Inventor
Peter Steck
A Pershouse
A Jasser
K Yung
V Tavtigian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myriad Genetics Inc
University of Texas System
Original Assignee
Myriad Genetics Inc
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myriad Genetics Inc, University of Texas System filed Critical Myriad Genetics Inc
Publication of DE69830596D1 publication Critical patent/DE69830596D1/de
Application granted granted Critical
Publication of DE69830596T2 publication Critical patent/DE69830596T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69830596T 1997-08-26 1998-08-26 Ein tumorsuppressor namens ts10q23.3 Expired - Lifetime DE69830596T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5775097P 1997-08-26 1997-08-26
US57750P 1997-08-26
US8356398P 1998-04-30 1998-04-30
US83563P 1998-04-30
PCT/US1998/017636 WO1999010537A1 (en) 1997-08-26 1998-08-26 A tumor suppressor designated ts10q23.3

Publications (2)

Publication Number Publication Date
DE69830596D1 true DE69830596D1 (de) 2005-07-21
DE69830596T2 DE69830596T2 (de) 2006-03-16

Family

ID=26736860

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69830596T Expired - Lifetime DE69830596T2 (de) 1997-08-26 1998-08-26 Ein tumorsuppressor namens ts10q23.3

Country Status (8)

Country Link
EP (1) EP1012338B1 (de)
JP (3) JP4339506B2 (de)
AT (1) ATE298003T1 (de)
AU (1) AU9120398A (de)
CA (1) CA2301199C (de)
DE (1) DE69830596T2 (de)
ES (1) ES2245039T3 (de)
WO (1) WO1999010537A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262242B1 (en) * 1997-01-30 2001-07-17 Board Of Regents, The University Of Texas System Tumor suppressor designated TS10Q23.3
US6482795B1 (en) 1997-01-30 2002-11-19 Myriad Genetics, Inc. Tumor suppressor designated TS10q23.3
US6284538B1 (en) * 1999-07-21 2001-09-04 Isis Pharmaceuticals, Inc. Antisense inhibition of PTEN expression
GB9918057D0 (en) * 1999-07-30 1999-10-06 Univ Bristol Therapeutic agents
US7041445B2 (en) * 1999-11-15 2006-05-09 Clontech Laboratories, Inc. Long oligonucleotide arrays
US20020025521A1 (en) 1999-11-29 2002-02-28 Lu Kun Ping Pin1 as a marker for abnormal cell growth
AU6513701A (en) * 2000-05-30 2001-12-11 Advanced Res & Tech Inst Compositions and methods for identifying agents which modulate pten function andpi-3 kinase pathways
JP2002142765A (ja) * 2000-07-14 2002-05-21 Tosoh Corp 新規ゲノム解析法
JP6472075B2 (ja) * 2015-02-26 2019-02-20 学校法人順天堂 Ｇｉｓｔの予後又は治療抵抗性の診断

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262242B1 (en) * 1997-01-30 2001-07-17 Board Of Regents, The University Of Texas System Tumor suppressor designated TS10Q23.3

Also Published As

Publication number Publication date
JP4454670B2 (ja) 2010-04-21
EP1012338A4 (de) 2002-11-20
AU9120398A (en) 1999-03-16
JP2008263988A (ja) 2008-11-06
DE69830596T2 (de) 2006-03-16
WO1999010537A1 (en) 1999-03-04
JP2010051330A (ja) 2010-03-11
CA2301199C (en) 2013-02-05
ES2245039T3 (es) 2005-12-16
CA2301199A1 (en) 1999-03-04
ATE298003T1 (de) 2005-07-15
EP1012338A1 (de) 2000-06-28
JP4339506B2 (ja) 2009-10-07
EP1012338B1 (de) 2005-06-15
JP2001514015A (ja) 2001-09-11

Similar Documents

Publication Publication Date Title
EP2366712A3 (de) TS10Q23.3 Tumorunterdrückung
TR200200937T2 (tr) Yumurtalık kanseri tedavisi için bileşimler.
TR200101482T2 (tr) WT1'e özgü imünoterapi için bileşimler
ATE259648T1 (de) Verbindungen die kolorektale krebszellen spezifisch binden und verfahren für ihre herstellung
TR200003087T2 (tr) Yeni CD19 X CD3 Spesifik polipeptidler ve kullanımları
DE59903921D1 (de) Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
EA199800391A1 (ru) Ингибирование роста опухоли антисмысловыми олигонуклеотидами к il-8 и il-8 рецептору
DE69837529D1 (de) Proteinmarker für lungenkrebs und deren verwendung
FI925986A0 (fi) Slumpartat bio-oligomer bibliotek, ett foerfarande foer syntetisering avdet samt ett foerfarande foer anvaendning av det
TR200003515T2 (tr) İkame edilmiş indolinon, bunların imalatı ve ilaç olarak kullanımı
ATE458050T1 (de) Promotion oder inhibition von angiogenese und kardiovaskularisation
ATE253903T1 (de) Methoden und pharmazeutische zusammenstellungen zur wachstumsverhinderung von tumorzellen enthaltend einen ppar-gamma agonisten und einen map kinase inhibitor
DK0858467T3 (da) Materialer og fremgangsmåder angående identifikationen og sekventeringen af BRCA2 cancerfölsomhedsgen og anvendelser deraf
DE69830596D1 (de) Ein tumorsuppressor namens ts10q23.3
DE602005014789D1 (de) Phosphorylierte vimentin als marker für die aggressivität und /oder invasivität von tumoren
ES2121993T3 (es) Derivados de 4-oxo-2-tioxoimidazolidina como sustancias inhibidoras de la agregacion de plaquetas sanguineas.
ATE332979T1 (de) Detektion von änderungen von tumor-suppressor genen zur diagnose von krebs
ATE175996T1 (de) Diagnose von krebs, dessen zellen das am tyrosin phosphorylierte crkl-protein exprimieren
DK0500602T3 (da) Middel til neutralisering af til tumorceller knyttet prokoagulantaktivitet
Goldenring et al. Isolation of brain Ca2+-calmodulin tubulin kinase containing calmodulin binding proteins
MX9702789A (es) Novedosas proteinas ligandos del dominio de la muerte del receptor tnf, e inhibidores de la union delos ligandos.
SE9500030D0 (sv) Method of determining metastatic potential of tumor cells
Paas et al. Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells
DE3577709D1 (de) Platin-intercalativ-komplexe zur behandlung von krebs.
EP0495910A4 (en) Production and use of human nm23 protein and antibodies therefor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition